Table of Contents

company-logo

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Lyra Therapeutics Dividend Announcement

• Lyra Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Lyra Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Lyra Therapeutics Dividend History

Lyra Therapeutics Dividend Yield

Lyra Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Lyra Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Lyra Therapeutics Financial Ratios

P/E ratio-0.17
PEG ratio-0.02
P/B ratio0.56
ROE-143.74%
Payout ratio0.00%
Current ratio3.60
Quick ratio3.60
Cash Ratio1.66

Lyra Therapeutics Dividend FAQ

Does Lyra Therapeutics stock pay dividends?
Lyra Therapeutics does not currently pay dividends to its shareholders.
Has Lyra Therapeutics ever paid a dividend?
No, Lyra Therapeutics has no a history of paying dividends to its shareholders. Lyra Therapeutics is not known for its dividend payments.
Why doesn't Lyra Therapeutics pay dividends?
There are several potential reasons why Lyra Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Lyra Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Lyra Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Lyra Therapeutics a dividend aristocrat?
Lyra Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Lyra Therapeutics a dividend king?
Lyra Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Lyra Therapeutics a dividend stock?
No, Lyra Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Lyra Therapeutics stocks?
To buy Lyra Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Lyra Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.